CBHD.F

Healthcare Medical Instruments & Supplies

Coloplast A/S

€56.48
+1.28 +2.32% today Live

Price History

Not enough data
Price chart data
DatePrice
Oct 7, 2026, live at 12:51 PM ET56.48

Key Stats

Market Cap
12.73B
Avg Volume
287
P/E (TTM)
34.44
EPS
€1.64
52W High
€82.96
52W Low
€49.72
Div. Yield
41.7%

Valuation

Forward P/E
14.41
P/B Ratio
7.12
P/S Ratio
0.45
EV/EBITDA
4.11
EV/Revenue
1.25
PEG Ratio
1.05

Margins

Gross Margin 67.2%
Operating Margin 26.2%
Net Margin 9.7%
EBITDA Margin 30.3%

Growth & Returns

Revenue Growth (YoY)
5.7%
Earnings Growth (YoY)
81.8%
Earnings Growth (QoQ)
81.6%
Return on Equity
18.5%
Return on Assets
10.1%

Liquidity & Leverage

Current Ratio
1.56
Quick Ratio
0.88
Debt / Equity
1.78
Total Cash
817.00M
Total Debt
23.80B

About

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

www.coloplast.com